Journal profile · CHEMISTRY, MEDICINAL
Future Medicinal Chemistry
ISSN 1756-8919 · eISSN 1756-8927 · Future Science · ENGLAND · Monthly · Founded 2009
Future Medicinal Chemistry: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.42; subscription journal; median 95 days to acceptance (110 articles, last 24 months); 220 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Future Medicinal Chemistry is published by Future Science and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Computational Drug Discovery Methods, Synthesis and biological activity and Click Chemistry and Applications, together about 33.7% of its articles. Its main subfields are Organic Chemistry and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.
Source: LetPub
Research area (LetPub): CHEMISTRY, MEDICINAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- Computational Drug Discovery MethodsComputer Science14.8%
- Synthesis and biological activityChemistry12.5%
- Click Chemistry and ApplicationsChemistry6.4%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.4%
- Human auditory perception and evaluationEngineering4.4%
- Cancer therapeutics and mechanismsBiochemistry, Genetics and Molecular Biology4.3%
- Synthesis and Biological EvaluationChemistry4.1%
- Cholinesterase and Neurodegenerative DiseasesMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.42LetPub ·
- CiteScore 2026-06
- 4.4LetPub ·
- SJR 2026-06
- 0.43LetPub ·
- SNIP 2026-06
- 0.59LetPub ·
- h-index
- 54LetPub ·
- h-index
- 111OpenAlex ·
- i10-index
- 1,622OpenAlex ·
- 2-year mean citedness
- 3.6OpenAlex ·
- Self-citation rate
- 3%LetPub ·
- Share of gold OA articles
- 2.3%LetPub ·
Volume
- Articles per year
- 189LetPub ·
Articles by year OpenAlex count · 3,243 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 169 | 127 | 128 |
| 2025 | 220 | 205 | 783 |
| 2024 | 187 | 161 | 1,164 |
| 2023 | 154 | 26 | 1,483 |
| 2022 | 125 | 25 | 1,044 |
| 2021 | 156 | 36 | 2,343 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
95 daysMedian, submission to acceptance · P25–P75 63 days – 127 days
- Acceptance to online
- median 18 days (110 articles)
- Submission to online
- median 115 days
- Sample
- 110 articles with submission and acceptance dates (448 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Future Science
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 2009
- ISSN
- 1756-8919
- Electronic ISSN
- 1756-8927
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Future Medicinal Chemistry
What CAS zone is Future Medicinal Chemistry in?
In the 2025 upgraded edition of the CAS Journal Ranking, Future Medicinal Chemistry is in Zone 4 of Medicine, and in Zone 4 of the minor category Chemistry, Medicinal. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Future Medicinal Chemistry?
The latest impact factor listed by LetPub is 3.42; CiteScore 4.4, h-index 111.
How long does peer review take at Future Medicinal Chemistry?
Based on the dates recorded on 110 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 95 days (interquartile range 63–127 days); authors report an average review time of 4–8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Future Medicinal Chemistry?
According to LetPub and DOAJ records, Future Medicinal Chemistry is indexed in SCIE and Scopus.
Is Future Medicinal Chemistry open access, and what is the APC?
Future Medicinal Chemistry is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .